Statin tolerability: In defence of placebo-controlled trials
Author:
Affiliation:
1. Nuffield Department of Population Health, University of Oxford, UK
2. Department of Medicine, Division of Endocrinology and Metabolism, New York University School of Medicine, USA
Publisher
Oxford University Press (OUP)
Subject
Cardiology and Cardiovascular Medicine,Epidemiology
Link
http://journals.sagepub.com/doi/pdf/10.1177/2047487315602861
Reference37 articles.
1. ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
2. Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)
3. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
4. Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients
5. Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: Design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Low-density lipoprotein-cholesterol lowering effect of a nutraceutical regimen with or without ezetimibe in hypercholesterolaemic patients with statin intolerance;Frontiers in Cardiovascular Medicine;2022-11-25
2. Safety of Statins and Nonstatins for Treatment of Dyslipidemia;Endocrinology and Metabolism Clinics of North America;2022-09
3. Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials;Journal of Clinical Lipidology;2022-05
4. Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-04-15
5. Low close red yeast rice with monacolin K lowers LDL cholesterol and blood pressure in Japanese with mild dyslipidemia: A multicenter, randomized trial;ASIA PAC J CLIN NUTR;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3